Clinical trial
Influence of Lipid-lowering Drugs in Patients Seropositive for HIV With Lipodystrophy in Resting Energy Expenditure and Total Energy Expenditure
NCT02530827 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Lipid-lowering Drugs in Patients Seropositive for HIV With Lipodystrophy in Resting Energy Expenditure and Total Energy Expenditure
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- November 30, 2014
- Enrollment
- 45 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv lipodystrophy syndrome, hiv/aids